Portfolio

We selectively take minority interest as compensation for our venture management, corporate development, and M&A advisory services with the objective of exiting at a profit once our portfolio companies have restructured or perform as expected.

[software]

[software services]

[consumer goods]


[medical technology and healthcare]

[biotechnology]

back to top